# SEG Drug HTML Final Closure Report

**Document ID:** `SEG_DRUG_HTML_FINAL_CLOSURE_REPORT`  
**Mode:** `OWNER GOVERNED MEDICAL CONTENT REVIEW`  
**Source:** Drug HTML  
**Ownership:** `SEG_INTERNAL_ASSET` for the declared retained artifact scope  
**Decision authority:** Dr. Alaa Al-Asfar — SEG Medical Content Owner; Emergency Medicine Physician; Project Lead  
**Execution timestamp:** `2026-08-22T15:24:29+00:00` — observed documentation timestamp; not a substitute for a completed clinical-review date

## 1. Final determination

The Drug HTML closure pathway is complete at the level of internal artifact locking and evidence-bounded owner-governed assessment. It is not complete at the level of source approval, clinical validation, drug-safety validation, rights clearance, canonical source closure, or normalization readiness.

**Final owner decision:** `OWNER_REQUIRES_FURTHER_REVIEW`  
**Final gate:** `BLOCKED_PENDING_EVIDENCE`

## 2. Closed items

| Closure item | Result | Boundary |
|---|---|---|
| Internal source/artifact identity | `LOCAL_INTAKE_ARTIFACT` | Confirms retained representation only |
| Artifact reference | `/home/ubuntu/upload/deepseek_html_20260615_a3266b.html` | Local retained artifact reference |
| Internal version identifier | `SEG-P0-DRUG-HTML-LOCAL-INTAKE-001` | Governance identifier, not canonical publication version |
| SHA-256 | `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac` | Retained-byte continuity only |
| Size/line count | 25,918 bytes / 394 lines | Artifact facts only |
| Structural inventory | 19 `summaryData`, 21 `quick`, 47 `drugList`, 20 `trapsList` | Structural observations, not clinical validation |
| Internal metadata definition | Defined with missing values preserved | Does not create a Content Record or import mapping |
| Controlled-use scope | Internal educational-development governance and controlled project access | Does not authorize public distribution, redistribution, or learner-facing production |
| Owner-governed review pathway | Defined and decision recorded | Does not substitute for source-specific review evidence or approval |

The metadata lock and structural inventory are traceability anchors. They do not certify the content as accurate, complete, current, safe, or appropriate for clinical use.[1] [2]

## 3. Medical assessment result

The available evidence supports only a bounded assessment of the retained structure and review requirements. Emergency-medicine relevance, drug-information organization as clinically sufficient, drug safety, dose accuracy, contraindication completeness, interaction safety, adverse-effect monitoring, and currentness were not established by an attributable completed clinical review.

The following required medical fields remain `NOT_ESTABLISHED`: drug identity/disambiguation, formulation and concentration, route, indications and emergency context, intended population, dose and units, administration, maximums, contraindications, precautions, interactions, adverse effects, toxicity, monitoring, safety notices, currency, citations, and exact entity/section locators. The absence of an observed pairwise interaction table remains an observation only and is not evidence that interactions are absent.

No drug fact, dose, interaction, contraindication, safety statement, or correction was added or modified.

## 4. Remaining blockers

| Gate | State | Remaining requirement |
|---|---|---|
| Canonical source identity | `BLOCKED` | Source title, publisher/custodian, original locator, and authoritative relationship |
| Canonical version/date | `BLOCKED` | Edition/release/version, publication/update date, and source-version locator |
| Provenance/lineage | `BLOCKED` | Origin, extraction/transformation history, recovery chain, and source-to-HTML linkage |
| Rights/display scope | `BLOCKED` | Rights/permission for retained material and any incorporated third-party text or data |
| Metadata/track/taxonomy | `BLOCKED` | Explicit professional track, taxonomy, and complete source-linked metadata |
| Emergency-medicine validation | `BLOCKED` | Attributable review with actual date/time, exact locators, findings, limitations, and disposition |
| Pharmacology/Drug Safety validation | `BLOCKED` | Separate safety review covering dose, interactions, contraindications, warnings, monitoring, and conflicts |
| Technical/HTML lineage review | `BLOCKED` | Representation and derivative-lineage assessment |
| Audit closure | `PENDING` | Append-only closure event linked to this record and exact artifact |
| Source approval | `NOT_GRANTED` | Separate explicit approval record, if later authorized |

## 5. Required next actions

The next allowed action is to preserve the HTML and metadata lock unchanged, assemble the canonical source/version, provenance, rights, metadata, and track evidence packet, and complete separate owner-governed Emergency Medicine, Pharmacology/Drug Safety, metadata, technical/lineage, rights/provenance, and audit reviews. Each review must use the exact artifact hash, exact section/entity locators, actual review date/time, attributable authority, findings, conflicts, limitations, and disposition.

If a critical issue is identified, it must be recorded as an explicit finding and disposition. Any future correction, OCR-like transformation, rewrite, or derivative requires separate authorization, new version/hash, change history, and append-only audit linkage. No correction is authorized by this report.

## 6. Final controls

```text
OWNER_REVIEW_DECISION = OWNER_REQUIRES_FURTHER_REVIEW
CURRENT_GATE = BLOCKED_PENDING_EVIDENCE
APPROVED_SOURCES = NONE
NORMALIZATION = BLOCKED_PENDING_APPROVED_SOURCE
READY_FOR_NORMALIZATION = NOT_SET
SOURCE_REGISTRY_APPROVAL_STATES = UNCHANGED
CONTENT_MODIFIED = FALSE
DRUG_SAFETY_CERTIFIED = FALSE
CLINICAL_PUBLICATION_APPROVED = FALSE
```

| Prohibited action | Result |
|---|---|
| Source approval | `NO` |
| External approval or rights clearance claim | `NO` |
| Clinical publication approval | `NO` |
| Content correction/rewrite | `NO` |
| Normalization/import | `NO` |
| Content Record/Zod/Prisma/SQL creation | `NO` |
| Activation/publication | `NO` |
| Database/application change | `NO` |

## 7. Audit linkage

The closure-assessment completion event is to be appended as `DRUG_HTML_CLOSURE_ASSESSMENT_COMPLETED` with the observed execution timestamp, the locked artifact hash, the decision `OWNER_REQUIRES_FURTHER_REVIEW`, and the limitations above. The event must not be interpreted as source approval or clinical certification.

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_METADATA_LOCK_RECORD.md "SEG Drug HTML Metadata Lock Record"

[2]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_CLOSURE_STATUS.md "SEG Drug HTML Closure Status"

[3]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_MEDICAL_CLOSURE_RECORD.md "SEG Drug HTML Medical Closure Record"

[4]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_OWNER_REVIEW_RECORD.md "SEG Drug HTML Owner Review Record"

[5]: file:///home/ubuntu/seg-internship-output/SEG_OWNER_REVIEW_AUTHORITY_POLICY.md "SEG Owner Review Authority Policy"

[6]: file:///home/ubuntu/seg-internship-output/SEG_P0_VERSION_CONTROL_REGISTER.md "SEG P0 Version Control Register"

**Document status:** `DRUG_HTML_FINAL_CLOSURE_RECORDED_REQUIRES_FURTHER_REVIEW`
